SOLUTIONS AT PHARMACY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
SOLUTIONS AT PHARMACY
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€85,507
2024 · €67,895+€17,613
Equity
€2.2m
2024 · €2.1m+€85,507
Cash
€209,002
2024 · €306,702-€97,700
Balance sheet total
€3.3m
2024 · €3.3m+€37,321
Largest movements
Assets
- Current investments +€219,061
up €219,061 (+11.7%), from €1.9m to €2.1m
- Cash -€97,700
down €97,700 (-31.9%), from €306,702 to €209,002
mainly Current investments (-€219,061) and Debts after one year (-€53,333)
- Financial fixed assets -€86,250
down €86,250 (-8.3%), from €1.0m to €954,856
Equity and liabilities
- Reserves +€85,507
up €85,507 (+4.3%), from €2.0m to €2.1m
- Debts after one year -€53,333
down €53,333 (-15.9%), from €334,999 to €281,666
Income statement
- Financial income +€29,915
up €29,915 (+65.2%), from €45,900 to €75,815
of which Financial income: +€26,755
- Gross operating margin -€23,595
down €23,595 (-11.1%), from €212,992 to €189,397
- Taxes +€6,287
up €6,287 (+11.3%), from €55,618 to €61,905
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€67,895
Gross operating margin
-€23,595
Depreciation
+€543
Other operating charges
-€253
Other operating items
+€15,591
Financial income
+€29,915
Financial charges
+€1,698
Taxes
-€6,287
Result 2025
€85,507
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€101,132
Investment
-€145,498
Financing
-€53,333
Cash 2024
€306,702
From operations (derived)
+€101,132
Net result for the year
+€85,507
Depreciation
+€1,770
Receivables within one year
+€9,365
Deferred charges and accrued income
-€657
Trade debts
-€5,239
Tax, wage and social debts
+€8,109
Other debts
+€2,207
Accrued charges and deferred income
+€70
Investment (derived)
-€145,498
Investment in fixed assets (net)
+€73,563
Current investments
-€219,061
Financing
-€53,333
Debts after one year
-€53,333
Cash 2025
€209,002
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,264,429 | €3,301,749 | +€37,321 | +1.1% |
| Fixed assets | 21/28 | €1,045,747 | €970,414 | -€75,333 | -7.2% |
| Tangible fixed assets | 22/27 | €4,641 | €15,558 | +€10,917 | +235% |
| Land and buildings | 22 | - | €7,030 | +€7,030 | |
| Plant, machinery and equipment | 23 | €565 | €169 | -€396 | -70.1% |
| Furniture and vehicles | 24 | €2,464 | €6,747 | +€4,282 | +174% |
| Other tangible fixed assets | 26 | €1,612 | €1,612 | = | 0.0% |
| Financial fixed assets | 28 | €1,041,106 | €954,856 | -€86,250 | -8.3% |
| Current assets | 29/58 | €2,218,682 | €2,331,335 | +€112,654 | +5.1% |
| Amounts receivable within one year | 40/41 | €44,711 | €35,346 | -€9,365 | -20.9% |
| Trade receivables | 40 | €29,691 | €25,213 | -€4,478 | -15.1% |
| Other amounts receivable | 41 | €15,020 | €10,133 | -€4,887 | -32.5% |
| Current investments | 50/53 | €1,865,934 | €2,084,996 | +€219,061 | +11.7% |
| Cash at bank and in hand | 54/58 | €306,702 | €209,002 | -€97,700 | -31.9% |
| Deferred charges and accrued income | 490/1 | €1,335 | €1,992 | +€657 | +49.3% |
| Total equity and liabilities | 10/49 | €3,264,429 | €3,301,749 | +€37,321 | +1.1% |
| Equity | 10/15 | €2,104,945 | €2,190,452 | +€85,507 | +4.1% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Reserves | 13 | €2,004,945 | €2,090,452 | +€85,507 | +4.3% |
| Distributable reserves | 133 | €2,004,945 | €2,090,452 | +€85,507 | +4.3% |
| Amounts payable | 17/49 | €1,159,483 | €1,111,297 | -€48,187 | -4.2% |
| Amounts payable after more than one year | 17 | €334,999 | €281,666 | -€53,333 | -15.9% |
| Financial debts | 170/4 | €334,999 | €281,666 | -€53,333 | -15.9% |
| Amounts payable within one year | 42/48 | €811,557 | €816,634 | +€5,077 | +0.6% |
| Current portion of amounts payable after more than one year | 42 | €57,778 | €57,778 | = | 0.0% |
| Trade debts | 44 | €6,204 | €965 | -€5,239 | -84.5% |
| Suppliers | 440/4 | €6,204 | €965 | -€5,239 | -84.5% |
| Advances received on contracts in progress | 46 | €744,333 | €744,333 | = | 0.0% |
| Taxes, remuneration and social security | 45 | €2,353 | €10,462 | +€8,109 | +345% |
| Taxes | 450/3 | €2,337 | €10,462 | +€8,125 | +348% |
| Remuneration and social security | 454/9 | €16 | - | -€16 | |
| Other amounts payable | 47/48 | €889 | €3,096 | +€2,207 | +248% |
| Accrued charges and deferred income | 492/3 | €12,928 | €12,997 | +€70 | +0.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,313 | €1,770 | -€543 | -23.5% |
| Other operating charges | 640/8 | €1,166 | €1,419 | +€253 | +21.7% |
| Non-recurring operating charges | 66A | €18,785 | €3,194 | -€15,591 | -83.0% |
| Gross operating margin | 9900 | €212,992 | €189,397 | -€23,595 | -11.1% |
| Operating profit (loss) | 9901 | €190,728 | €183,014 | -€7,714 | -4.0% |
| Financial income | 75/76B | €45,900 | €75,815 | +€29,915 | +65.2% |
| Recurring financial income | 75 | €27,673 | €54,428 | +€26,755 | +96.7% |
| Non-recurring financial income | 76B | €18,226 | €21,387 | +€3,160 | +17.3% |
| Financial charges | 65/66B | €113,115 | €111,416 | -€1,698 | -1.5% |
| Recurring financial charges | 65 | €26,865 | €25,166 | -€1,698 | -6.3% |
| Non-recurring financial charges | 66B | €86,250 | €86,250 | = | 0.0% |
| Profit (loss) for the period before taxes | 9903 | €123,513 | €147,412 | +€23,899 | +19.3% |
| Income taxes | 67/77 | €55,618 | €61,905 | +€6,287 | +11.3% |
| Profit (loss) for the period | 9904 | €67,895 | €85,507 | +€17,613 | +25.9% |
| Profit (loss) for the period to be appropriated | 9905 | €67,895 | €85,507 | +€17,613 | +25.9% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.